What’s in Issue 030? *What is COVAX? With a fast-moving pandemic, no one is safe, unless everyone is safe As rich countries race to inoculate their...
What’s in Issue 029? ⋆AstraZeneca benefits outweigh risks France, Italy and Germany have announced plans to resume AstraZeneca coronavirus vaccinations after Europe’s drug regulator said the...
What’s in Issue 028? ⋆Vaccine supply problems may push national rollout into 2022 Some Australians may have to wait until early next year for their...
What’s in Issue 027? ⋆ Survey shows the vast majority Australian are still keen for the jab As Australia’s vaccine rollout slowly gathers pace with...
What’s in Issue 026? ⋆ Australia’s COVID vaccine rollout numbers tracking The single biggest and most complex vaccine campaign in the nation’s history has...
What’s in Issue 025? ⋆Thousands of frontline workers get Pfizer jab Thousands of frontline workers in Australia have begun receiving the COVID-19 vaccine, with...
What’s in Issue 024? ⋆ Victoria exposure sites list grows On 15th Feb, three Melbourne hospital psychiatric wards have been locked down and more than...
What’s in Issue 023? ⋆ Once vaccines roll out, Covid case numbers will no longer a focus Scott Morrison has ordered a review of the way...
What’s in Issue 021? ⋆ COVID-19 vaccine Pfizer is approved for use in Australia The nation’s medical regulator the Therapeutic Goods Administration has approved Pfizer’s...
What’s in Issue 020? ⋆ The mutant UK COVID-19 strain is changing Australia’s coronavirus quarantine protocols A woman who contracted the mutant UK strain...